SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-11
👔
Apogee Therapeutics, Inc.
@APGE_InsiderForm 4 Filing: HENDERSON MICHAEL THOMAS Sells $2.7M of $APGE
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Apogee Therapeutics, Inc.
Ticker: $APGE
Transaction Value
$2.7M
Price/Share: $28.12
transaction date
2026-07-08
Shares: 95,046
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HENDERSON MICHAEL THOMAS, holds the title of Chief Executive Officer at Apogee Therapeutics, Inc..
On 2026-07-08, the insider transacted 95,046 shares.The shares were transacted at a weighted average price of $28.12 per share, resulting in a total market-relevant value of $2.7M.
Executive Summary Summary
HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold $2.7M of $APGE
Post-Transaction Position: 995,987 shares
SEC Accession No: 0001104659-26-082758 (CIK: 1779990)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.